Literature DB >> 8542139

Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis.

A L Kritski1, M J Marques, M F Rabahi, M A Vieira, E Werneck-Barroso, C E Carvalho, G de N Andrade, R Bravo-de-Souza, L M Andrade, P P Gontijo, L W Riley.   

Abstract

Multidrug-resistant tuberculosis (MDRTB) has emerged as a major public health problem worldwide. To determine the incidence and risk factors associated with tuberculosis among contacts of MDRTB index cases, we studied human immunodeficiency virus-seronegative close contacts of 64 culture-confirmed MDRTB patients in Rio de Janeiro, Brazil. Between March 1988 and July 1992, tuberculosis developed in 17 (7.8%) of 218 previously healthy close contacts of 64 MDRTB index cases (1.6 cases per 1,000-person-months of contact). Among strains of Mycobacterium tuberculosis isolated from 13 contacts of 12 index cases, six (46%) had susceptibility patterns identical to those of their index cases, four (31%) had different patterns of resistance, and three (23%) were susceptible to all drugs. Tuberculosis developed more frequently in male contacts (p < 0.05), persons > or = 15 yr of age (p < 0.05), nonwhites (p < 0.001), and persons not previously vaccinated with bacillus Calmette-Guerin (BCG) (p < 0.05). The association of BCG vaccination with decreased risk of disease was significant even when this variable was controlled (by Cox's regression analysis) for age, sex, race, purified protein derivative (PPD) status, and isoniazid prophylaxis. BCG vaccination appears to offer protection against tuberculosis during prolonged exposures to persons with MDRTB, which identifies a novel and specific indication of BCG use.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8542139     DOI: 10.1164/ajrccm.153.1.8542139

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  32 in total

1.  Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings.

Authors:  David A J Moore; Daniel Mendoza; Robert H Gilman; Carlton A W Evans; María-Graciela Hollm Delgado; Jose Guerra; Luz Caviedes; Daniel Vargas; Eduardo Ticona; Jaime Ortiz; Giselle Soto; Jose Serpa
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

2.  Isoniazid Preventive Therapy in Contacts of Multidrug-Resistant Tuberculosis.

Authors:  Chuan-Chin Huang; Mercedes C Becerra; Roger Calderon; Carmen Contreras; Jerome Galea; Louis Grandjean; Leonid Lecca; Rosa Yataco; Zibiao Zhang; Megan Murray
Journal:  Am J Respir Crit Care Med       Date:  2020-10-15       Impact factor: 21.405

Review 3.  Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis.

Authors:  A Fraser; M Paul; A Attamna; L Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

Review 4.  Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus".

Authors:  P Farmer; J Y Kim
Journal:  BMJ       Date:  1998-09-05

5.  Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene.

Authors:  Y Suzuki; C Katsukawa; A Tamaru; C Abe; M Makino; Y Mizuguchi; H Taniguchi
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

Review 6.  Multi-drug resistant childhood tuberculosis.

Authors:  Varinder Singh; Satnam Kaur
Journal:  Indian J Pediatr       Date:  2010-12-31       Impact factor: 1.967

7.  Rapid screening of inhibitors of Mycobacterium tuberculosis growth using tetrazolium salts.

Authors:  Anita G Amin; Shiva K Angala; Delphi Chatterjee; Dean C Crick
Journal:  Methods Mol Biol       Date:  2009

Review 8.  The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guérin (BCG) vaccines: is there a link?

Authors:  F Abebe; G Bjune
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

9.  Hospital control and multidrug-resistant pulmonary tuberculosis in female patients, Lima, Peru.

Authors:  F F Willingham; T L Schmitz; M Contreras; S E Kalangi; A M Vivar; L Caviedes; E Schiantarelli; P M Neumann; C Bern; R H Gilman
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

Review 10.  Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis.

Authors:  N Sarita Shah; Courtney M Yuen; Moonseong Heo; Arielle W Tolman; Mercedes C Becerra
Journal:  Clin Infect Dis       Date:  2013-09-24       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.